The Under the Radar report suggests a profit of $4b for Retts and Fragile X during the orphan drug exclusivity period (7 years in the US, 10 years in Europe). Bell Potter estimates peak global sales of approx. US$3b per annum for Rett and Fragile X.
- Forums
- ASX - By Stock
- Ann: Annual Report to shareholders-NEU.AX
The Under the Radar report suggests a profit of $4b for Retts...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.00 |
Change
-0.720(3.47%) |
Mkt cap ! $2.570B |
Open | High | Low | Value | Volume |
$20.41 | $20.45 | $19.92 | $2.466M | 122.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 92 | $20.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.01 | 40 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 27 | 19.960 |
5 | 850 | 19.950 |
4 | 376 | 19.940 |
7 | 689 | 19.930 |
3 | 244 | 19.920 |
Price($) | Vol. | No. |
---|---|---|
19.970 | 69 | 4 |
19.980 | 87 | 2 |
19.990 | 243 | 4 |
20.000 | 589 | 5 |
20.010 | 464 | 4 |
Last trade - 12.45pm 25/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |